Broadpoint Capital
View More Recent Stories
-
Oscient Pharmaceuticals (OSCI) Cuts 32% of Workforce
-
Broadpoint Capital Upgrades Hoku (HOKU) to Buy
-
Broadpoint Starts Westport Innovations (WPRT) at Buy
-
Broadpoint Capital Downgrades Healthways (HWAY) to Neutral
-
Broadpoint Capital Downgrades Comverge (COMV) to Neutral
-
Broadpoint Capital Starts Magellan Health (MGLN) at Buy
-
Broadpoint Capital Downgrades Clean Energy (CLNE) to Buy
-
Notable Analyst Rating Changes 8/8: DCP, Q, ISIS, FSYS Upgraded; BAC, ABK, VOD, KNOT, ANAD Downgraded
-
Broadpoint Upgrades Fuel Systems (FSYS) to Strong Buy
-
Broadpoint Upgrades Verenium (VRNM) to Buy
-
Notable Analyst Rating Changes 8/4: CX, NEU, CHK, AKAM Upgraded; DE, AKS, ESRX, ELN Downgraded
-
Broadpoint Downgrades Express Scripts (ESRX) to Buy
-
Unusual 11 Mid-Day Movers 7/30: BBSI, ACLI, TWP, SVVS Higher; ELN, SIMO, LFG, XPRT Lower
-
Broadpoint Downgrades Ultimate Software (ULTI) to Neutral
-
Broadpoint Downgrades Omniture (OMTR) to Neutral
-
Notable Analyst Rating Changes 7/18: C, SPWR, XTO, UAUA Upgraded; VCLK, GILD, MER, BBY Downgraded
-
Broadpoint Upgrades SunPower (SPWR) to Buy

